A T A C
  • A T A C Consortium
    • Principal Investigators
  • Press Releases
  • Relevant Publications
  • Contact Us
Select Page

Relevant Publications

Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity

Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals

Development of passive immunity against SARSCoV-2 for management of immunodeficient patients—a perspective

Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter interventional trial

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface

Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo

Evolution of Antibody Immunity to SARS-CoV-2

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection

Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003650. This website reflects only the author's view and the European Commission is not responsible for any use that may be made of the information it contains.